1. Home
  2. AIMD vs BREA Comparison

AIMD vs BREA Comparison

Compare AIMD & BREA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AIMD
  • BREA
  • Stock Information
  • Founded
  • AIMD 1984
  • BREA 2022
  • Country
  • AIMD United States
  • BREA Ireland
  • Employees
  • AIMD N/A
  • BREA N/A
  • Industry
  • AIMD Biotechnology: Pharmaceutical Preparations
  • BREA Services-Misc. Amusement & Recreation
  • Sector
  • AIMD Health Care
  • BREA Consumer Discretionary
  • Exchange
  • AIMD Nasdaq
  • BREA Nasdaq
  • Market Cap
  • AIMD 8.5M
  • BREA 8.7M
  • IPO Year
  • AIMD N/A
  • BREA 2023
  • Fundamental
  • Price
  • AIMD $0.62
  • BREA $0.65
  • Analyst Decision
  • AIMD
  • BREA
  • Analyst Count
  • AIMD 0
  • BREA 0
  • Target Price
  • AIMD N/A
  • BREA N/A
  • AVG Volume (30 Days)
  • AIMD 227.7K
  • BREA 49.7K
  • Earning Date
  • AIMD 03-07-2025
  • BREA 01-03-2025
  • Dividend Yield
  • AIMD N/A
  • BREA N/A
  • EPS Growth
  • AIMD N/A
  • BREA N/A
  • EPS
  • AIMD N/A
  • BREA N/A
  • Revenue
  • AIMD $40,633.00
  • BREA $2,872,101.00
  • Revenue This Year
  • AIMD N/A
  • BREA N/A
  • Revenue Next Year
  • AIMD N/A
  • BREA N/A
  • P/E Ratio
  • AIMD N/A
  • BREA N/A
  • Revenue Growth
  • AIMD N/A
  • BREA 2338.69
  • 52 Week Low
  • AIMD $0.40
  • BREA $0.50
  • 52 Week High
  • AIMD $3.10
  • BREA $2.44
  • Technical
  • Relative Strength Index (RSI)
  • AIMD 47.20
  • BREA 44.80
  • Support Level
  • AIMD $0.56
  • BREA $0.60
  • Resistance Level
  • AIMD $0.77
  • BREA $0.67
  • Average True Range (ATR)
  • AIMD 0.06
  • BREA 0.04
  • MACD
  • AIMD -0.01
  • BREA 0.00
  • Stochastic Oscillator
  • AIMD 28.67
  • BREA 56.04

About AIMD Ainos Inc.

Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.

About BREA Brera Holdings PLC

Brera Holdings PLC focused on expanding social impact football by developing a international portfolio of emerging football clubs with increased opportunities to earn tournament prizes, gain sponsorships, and provide other professional football and related consulting services.

Share on Social Networks: